Hyperglycaemia News and Research

RSS

Improved primary care may help reduce hospital readmissions for diabetes patients

PEOPLE who regularly visit their family doctor following discharge for a diabetes-related hospitalisation significantly reduce their chance of being readmitted, an Australian study has found

7 Mar 2017

Scientists establish ‘tipping point’ molecular link between blood sugar and Alzheimer's disease

For the first time a "tipping point" molecular link between the blood sugar glucose and Alzheimer's disease has been established by scientists, who have shown that excess glucose damages a vital enzyme involved with inflammation response to the early stages of Alzheimer's.

24 Feb 2017

High rates of scanning with Abbott′s FreeStyle Libre system linked to improved glucose control in diabetes patients

Abbott today announced the results of real-world use data showing that people who scan more frequently using Abbott′s FreeStyle Libre system spend less time in hypoglycaemia (low blood sugar) or hyperglycaemia (high blood sugar) while having improved average glucose levels.

16 Feb 2017

Sphere Medical study finds high variability in glycaemic control practices across northwest European ICUs

Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, has recently presented at the Intensive Care Society State of the Art Meeting and published a scientific poster discussing, “A comparative survey of glycaemic control practice in the UK, Germany and BeNeLux”.

2 Feb 2017

Sphere Medical launches next generation Proxima for bedside blood gas and glucose analysis

Sphere Medical, an innovative company in critical care monitoring and diagnostics equipment, has launched its next generation CE-marked Proxima system.

17 Dec 2016

Survey: Only 1 in 3 patients discusses symptoms of hyperglycaemia with nurse or doctor

Only 1 in 3 discussed symptoms of high blood glucose levels (hyperglycaemia) with their nurse or doctor, according to a new survey of 200 people living with type 1 or type 2 diabetes, who need mealtime insulin to control their blood glucose levels.

8 Dec 2016

NRS Healthcare creates video and infographic to raise awareness of diabetes

In order to raise awareness around Type 1, Type 2 and Gestational Diabetes as well as “Diabulimia”, a recently reported condition where young people with diabetes choose not to take their insulin in order to lose weight, NRS Healthcare has created an informational infographic and video.

11 Nov 2016

Poor PPG control has significant negative impact on quality of life for diabetic people

New data from the first health-related quality of life (HRQL) study related to post-meal or postprandial glucose (PPG) control, show that poor PPG control has a significant negative impact on quality of life for people with diabetes.

2 Nov 2016

Foul smelling gas could help people with diabetes recover from heart complications

A gas that was formerly known for its noxious qualities could help people with diabetes recover from common heart and blood vessel complications, concludes research led by the University of Exeter Medical School.

1 Sep 2016

Hydrothermal DMR results show promise in treatment of type 2 diabetes

Fractyl Laboratories Inc. (Fractyl) announced today publication of data in the current issue of Diabetes Care from the Company’s first-in-human study of RevitaTM duodenal mucosal resurfacing (Revita DMR).

17 Aug 2016

Taking vitamin D with quetiapine can help avoid new-onset diabetes risk

Atypical antipsychotics, though effective for treating disorders like schizophrenia, bipolar disorder, and depression, gives patients a heightened risk of developing new-onset diabetes.

3 Jun 2016

Diabetes societies endorse 'metabolic surgery'

An "unprecedented" number of societies have endorsed guidelines recommending metabolic surgery for patients with diabetes - and not just for patients with severe obesity.

27 May 2016

Normoglycaemia key to improved neurological outcome after paediatric stroke

Achieving normal blood glucose concentrations may be important in preventing poor neurological outcomes in children following acute arterial ischemic stroke, a retrospective review indicates.

27 May 2016

Oral regimens could offer simple solution for severe hyperglycaemia

Study findings indicate that oral treatments could offer a simpler alternative to upfront insulin for patients who have severe hyperglycaemia at the time of diagnosis with Type 2 diabetes.

10 May 2016

AstraZeneca reports new Phase I extended follow-up data on osimertinib in NSCLC patients at ELCC 2016

AstraZeneca today reported new Phase I extended follow-up data on osimertinib in both first- and second-line treatment of patients with non-small cell lung cancer (NSCLC), at the European Lung Cancer Conference (ELCC) 2016. Late-breaker presentations reinforced the efficacy and safety profile for osimertinib previously seen in the AURA clinical trials programme.

15 Apr 2016

Cardiovascular considerations crucial for CML TKI patients

A review of BCR–ABL1 tyrosine kinase inhibitors highlights the need to consider cardiovascular adverse event risk profiles when prescribing for patients with chronic myeloid leukaemia.

22 Jan 2016

IQWiG: Benefit of proteome analysis for detection of diabetic nephropathy remains unclear

The German Institute for Quality and Efficiency in Health Care examined the benefit of a diagnostic-therapeutic strategy using urinary proteome analysis for detection of diabetic nephropathy (DN) versus a conventional diagnostic strategy in patients with diabetes mellitus and arterial hypertension. After publication of the preliminary report in June 2015, interested persons and parties had the opportunity to comment on the preliminary results.

26 Nov 2015

New collaboration aims to develop novel generation artificial pancreas

Debiotech SA, the ARTORG Center for Biomedical Engineering Research of the University of Bern - and the Division of Endocrinology, Diabetes and Clinical Nutrition of the Bern University Hospital "Inselspital" are proud to announce the start of an exclusive collaboration to develop a novel generation artificial pancreas.

24 Nov 2015

New generation of incretin-based medicines allows coordinated action against diabesity

The new generation of incretin-based medicines will allow a coordinated action against the combination diabetes/obesity, also known as diabesity, in some cases with only a single weekly dose, and with the likelihood of additional beneficial effects on other health complications related to this condition, such as cardiovascular and neurodegenerative diseases.

28 Oct 2015

CV risk assessment essential for CML TKI trial design

The risk and impact of cardiovascular adverse events in long-term users of tyrosine kinase inhibitors for chronic myeloid leukaemia is highlighted in a review published in the Journal of Clinical Oncology.

22 Oct 2015